Vacuum erection devices ameliorate erectile dysfunction in diabetic rats via Piezo1/NFATc1-mediated mechanotransduction

Background The use of a vacuum erection device (VED) is an effective non-invasive therapy for Diabetes mellitus-induced erectile dysfunction (DMED); however, its molecular mechanism remains unclear. This study investigated whether VED exerts therapeutic effects against DMED by protecting corpus cavernosum smooth muscle cells (CCSMCs) via Piezo1/NFATc1 mechanotransduction. Methods Rats with streptozotocin-induced DMED were treated with VED alone or in combination with the Piezo1 agonist Yoda1 or inhibitor GsMTx4. Erectile function was evaluated by the ICP/MAP ratio, cavernosal apoptosis, and fibrosis. Primary rat CCSMCs subjected to cyclic mechanical stretching were used to mimic VED stimulation in vitro . The Piezo1/NFATc1 signalling axis was validated using pharmacological intervention, siRNA knockdown, calcium imaging, and transcriptomic analysis. Results VED treatment significantly improved erectile function and attenuated cavernosal apoptosis and fibrosis, concomitant with Piezo1 upregulation and NFATc1 dephosphorylation and nuclear translocation. Pharmacological activation of Piezo1 by Yoda1 recapitulated these protective effects, whereas Piezo1 inhibition or knockdown abrogated these benefits. NFATc1 knockdown further abolished the anti-apoptotic, anti-fibrotic and contractility-preserving effects induced by Piezo1 activation in CCSMCs. Conclusion VED ameliorates DMED by activating Piezo1, which drives Ca 2+ /calcineurin-dependent NFATc1 signaling to protect cavernosal smooth muscle, maintain its contractility, and suppress apoptosis and fibrosis. This Piezo1/NFATc1 mechanotransduction cascade represents a promising therapeutic target for DMED and provides a mechanistic rationale for developing related pharmacotherapies.

Authors

Institutions

Publication Details

Journal
Frontiers in Pharmacology
Published
2026-11-18
DOI
https://doi.org/10.3389/fphar.2026.2004480
Primary Topic
Sexual function and dysfunction studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Vacuum erection devices ameliorate erectile dysfunction in diabetic rats via Piezo1/NFATc1-mediated mechanotransduction

Guangqian Gao, Yurong Xiang, 何书华, Haibo Zhang et al.
2 links
Frontiers in Pharmacology
Sexual function and dysfunction studies
article

Vacuum erection devices ameliorate erectile dysfunction in diabetic rats via Piezo1/NFATc1-mediated mechanotransduction

Guangqian Gao, Yurong Xiang, 何书华, Haibo Zhang, Yuanhui Liu, Yincheng Fan, Miaoxia Pan, Anyang Wei
article en

Abstract

Background The use of a vacuum erection device (VED) is an effective non-invasive therapy for Diabetes mellitus-induced erectile dysfunction (DMED); however, its molecular mechanism remains unclear. This study investigated whether VED exerts therapeutic effects against DMED by protecting corpus cavernosum smooth muscle cells (CCSMCs) via Piezo1/NFATc1 mechanotransduction. Methods Rats with streptozotocin-induced DMED were treated with VED alone or in combination with the Piezo1 agonist Yoda1 or inhibitor GsMTx4. Erectile function was evaluated by the ICP/MAP ratio, cavernosal apoptosis, and fibrosis. Primary rat CCSMCs subjected to cyclic mechanical stretching were used to mimic VED stimulation in vitro . The Piezo1/NFATc1 signalling axis was validated using pharmacological intervention, siRNA knockdown, calcium imaging, and transcriptomic analysis. Results VED treatment significantly improved erectile function and attenuated cavernosal apoptosis and fibrosis, concomitant with Piezo1 upregulation and NFATc1 dephosphorylation and nuclear translocation. Pharmacological activation of Piezo1 by Yoda1 recapitulated these protective effects, whereas Piezo1 inhibition or knockdown abrogated these benefits. NFATc1 knockdown further abolished the anti-apoptotic, anti-fibrotic and contractility-preserving effects induced by Piezo1 activation in CCSMCs. Conclusion VED ameliorates DMED by activating Piezo1, which drives Ca 2+ /calcineurin-dependent NFATc1 signaling to protect cavernosal smooth muscle, maintain its contractility, and suppress apoptosis and fibrosis. This Piezo1/NFATc1 mechanotransduction cascade represents a promising therapeutic target for DMED and provides a mechanistic rationale for developing related pharmacotherapies.

Frontiers in PharmacologyVol. 17
Nanfang Hospital (CN), Southern Medical University (CN)
Good health and well-being
Sexual function and dysfunction studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon